Our Cells

RESTEM has developed world-leading cellular therapeutics to evolve innovative allogeneic cellular medicines to treat complex inflammatory diseases.

More info

COVID19 Response

RESTEM is committed to the development of technologies that ensure our world’s health and wellbeing.
Presently, we are in clinical studies for COVID19 presenting solutions for unmet needs.

Clinical Trials

We are proud donors of cGMP stem cells for clinical studies. Presently, moving forward with clinical studies on Autoimmune diseases, COVID19, Duchenne Muscular Dystrophy and Heart Failure secondary issues following left ventricular assisted.

News

Our Partners

We are proud to collaborate with some of the leading health research institutes in the development of best in class cellular therapeutics to evolve human health.